Combination of QT Variability and Signalaveraged Electrocardiography in Association With Ventricular Tachycardia in Postinfarction Patients
|
|
- Willis Fisher
- 5 years ago
- Views:
Transcription
1 Journal of Electrocardiology Vol. 36 No Combination of QT Variability and Signalaveraged Electrocardiography in Association With Ventricular Tachycardia in Postinfarction Patients Gulmira Kudaiberdieva, MD, FESC, Bulent Gorenek, MD, Omer Goktekin, MD, Yuksel Cavusoglu, MD, Alpaslan Birdane, MD, Ahmet Unalir, MD, Necmi Ata, MD, and Bilgin Timuralp, MD Abstract: The authors investigate incidence of ventricular tachycardia/ventricular fibrillation (VT/VF) in relationship with combination of noninvasive arrhythmia risk markers as left ventricular ejection fraction (LVEF), late potentials (LP), and QT variability index (QTVI) and compare the utility of their combination in association with sustained ventricular arrhythmias in patients after myocardial infarction (MI). Fifty-four patients with old MI, among them 27 with documented spontaneous sustained VT/VF entered the study. All of them underwent evaluation for arrhythmias and noninvasive risk stratificaton. Logistic regression analysis demonstrated that the highest association with ventricular tachyarrhythmia had combination of LP and increased QTVI (13.8, P.0002), followed then by combination of LVEF and LP (12.2, P.0005), LP alone (P.001), QTVI (P.002) and LVEF (P.003) alone and age (P.01). After stepwise regression analysis showed that the model including association of LP and QTVI, age and EF is the best one for delineating patients having the risk of ventricular tachyarrhythmia development. In conclusion, patients with combination of positive LP and increased QTVI after MI have high likelihood for development of serious sustained arrhythmia. Key words: Ventricular tachycardia, QT variability, late potentials, ejection fraction, myocardial infarction. Identification and selection of patients with the highest risk for arrhythmic and sudden death are From the Osmangazi University, Medical Faculty, Cardiology Department, Eskisehir, Turkey. Reprint requests: Gulmira Kudaiberdieva, MD, Beyazevler Mah. 26 Sokak, Irem Apt, Kat 1, No 2, Adana, Turkey; gulmira_kudaiberdieva@hotmail.com. Copyright 2003, Elsevier Science (USA). All rights reserved /03/ $35.00/0 doi: /jelc still considered as the main problem of management of patients after myocardial infarction (MI). Several noninvasive markers for arrhythmic events as reduced heart rate variability (HRV), abnormal baroreflex sensitivity, presence of late potentials (LP) on signal-averaged electrocardiogram (SAECG), T wave alternans and QT dispersion are used in risk stratification of patients after MI (1-10). Their predictive accuracy for sudden or arrhythmic death alone or in combination with ejection fraction, nonsustained 17
2 18 Journal of Electrocardiology Vol. 36 No. 1 January 2003 ventricular tachycardia and ventricular extrasystolia on Holter ECG recordings has been evaluated in prospective studies with reported different predictive values (2,4,11-14). On the other hand left ventricular (LV) dysfunction is a well established predictor of sudden and arrhythmic death in patients after MI, specially those with values 30% had the most strong benefit from automated implantable cardioverter defibrillators therapy (15-17). Recently, QT interval variability index (QTVI) (18,19) has been found to have high prognostic value in prediction of sudden death in structural heart disease population (20). Assuming (LV) dysfunction and scar formation with slowing of conduction between viable and non-viable tissues, as well transient factors as ischemia in patients after MI may predispose to arrhythmic events (21-23), the combination of LV dysfunction index with markers of abnormal conduction and repolarization seems to be attractive approach in determining the risk for arrhythmias in patients after MI. We aimed to investigate incidence of ventricular tachycardia/ventricular fibrillation (VT/VF) in relationship with combination of noninvasive arrhythmia risk markers as LVEF, SAECG, and QTVI and to compare the utility of their combination in association with sustained ventricular arrhythmias patients after myocardial infarction. Material and Methods Fifty-four patients with old MI, among them 46 men and 8 women without signs of bundle branch block and atrial fibrillation underwent arrhythmia evaluation in our clinic entered the study. Clinical examinations, chest x-ray, 12-lead electrocardiogram (ECG) and 24 hours ECG monitoring were performed in all patients. Two-dimensional echocardiography was accomplished using 3.75 MHz transducer (Acuson, Sequoia C256) due to recommendations of the American Society of Echocardiography (25) and apical two-chamber views were used for measurement of LV volumes (area-length method) and ejection fraction. Thirty patients with syncope, history of sudden death, sustained and nonsustained ventricular tachycardia underwent programmed ventricular stimulation from right ventricular apex and right ventricular outflow tract using one to triple premature ventricular stimuli with and without isoproterenol infusion until induction of clinical ventricular tachycardia. Coronary angiography was done by Judkins technique with estimation of the mean number of stenosed vessels (arterial narrowing of 50% in planar and 75% cross-sectional views were accepted as significant) and infarct-related artery (IRA) patency in all patients. All patients underwent short-term high-resolution ECG recordings using Kardiosis ard-lp PC based high resolution system with further analysis of SAECG, HRV and QT variability. Bipolar Frank X, Y, Z derivations ( Hz) were recorded and sampled at rate of 1000 samples per second and digitized using 12 bit A/D converter. Each recording lasted for 7 minutes and data were stored in disk for postprocessing analysis. Signal-averaged ECG analysis with estimation of LP was done by time-domain measurements of the vector magnitude in X, Y, Z leads after high-pass filtering ( Hz), amplification and averaging of QRS complexes. The following parameters were assessed: mean filtered QRS duration (fqrs), the root mean square voltage of the terminal (40 ms) portion of the filtered QRS complex (RMS 40) and duration of the low-amplitude ( 40 V) signal in the terminal filtered QRS complex (LAS40). The LP were accepted as positive when RMS40 20 V and LAS40 38 ms (26). The acceptable mean noise level was 0.7 V. QT variability index. Time and frequency domain analysis of heart rate and QT interval variability was done after extracting of RR and QT tachograms from the signal. The detection of R wave was performed after visual selection of R wave sample and then by cross correlation template matching algorithm method of the consecutive R waves. Detection of T waves and Q waves for QT variability analysis was performed using similar algorithm from the leads with the maximum T wave amplitude. End of the T wave was selected as the intercept point of the T wave slope met the TP baseline at the steepest angle. For Q wave in the same lead the onset of QRS was considered. Then RR and QT duration sequences were obtained and interpolated by linear interpolation with further construction of one second equally spaced RR and QT tachograms. To obtain power spectrums a Fast Fourier transformation was used and following time and spectral domain measures were extracted: mean RR and QT intervals durations, standard deviation of normal to normal adjacent RR intervals (SDNN) and QT intervals, total variance of RR and QT variability s, total powers under spectral RR and QT variability s curves. Then QTVI was calculated with a formula
3 QT Variability Data Potentials, Ventricular Tachycardia after MI Kudaiberdieva et al. 19 Table 1. Clinical Characteristics Parameters Group I Group II P Age, years Gender Male, % 85.2 (23) 85.2 (23) NS Female, % 14.8 (4) 14.8 (4) Smoking, % 51.8 (14) 70.4 (19) NS Diabetes, % 29.6 (8) 7.4 (2).07 Hypertension, % 70.3 (19) 59.3 (16) NS Presentation Syncope, % 59.3 (16) 22.2 (6).001 Palpitations, % 18.5 (5) 11.1 (3) History of sudden death, % 14.8 (4) - Monomorphic VT, % 71.4 (20) - Polymorphic VT/VF, % 28.5 (7) - NSVT, % (2) Treatment Beta-blockers, % 14.8 (4) 25.9 (7) NS ACE inhibitors, % 44.4 (12) 51.8 (14) NS Class III antiarrhythmic drugs, % 51.9 (14) 15.4 (4).06 CAD extent NS IRA occlusion, % 51.9 (14) 48.1 (13) NS PVS 23 7 VT, % 82.6 (19) - VT, % 17.3 (4) 100 EF, % MRR, ms NS SDNN, ms MQTc, ms NS fqrs, ms LAS40, ms RMS40 ( V) QTVI ACE, angiotensin-converting enzyme; CAD, coronary artery disease; EF, ejection fraction; fqrs, filtered QRS duration; IRA, infarct-related artery; LAS40, duration of the low-amplitude ( 40 V) signal in the terminal filtered QRS complex; RMS40, the root mean square voltage of the terminal (40 ms) portion of the filtered QRS complex; LP, late potential; MQTc, mean corrected QT duration; MRR, mean RR interval; NS, nonsignificant; NSVT, nonsustained ventricular tachycardia; QTVI, QT variability index; VEB, ventricular ectopic beats; VT/VF, ventricular tachycardia/ventricular fibrillation. proposed by Berger et al. (17,18). QT interval correction was made by using the Bazett formula. Patients groups. According with clinical records and arrhythmia evaluation all patients were divided into 2 groups: group I, 27 patients with clinically documented episodes of spontaneous sustained VT/VF and group II, 27 patients without sustained VT/VF.. Patients were further subdivided into subgroups after dichotomization of noninvasive arrhythmia markers: LV EF 35% and 35% (16,17), presence or absence of LP on SAECG (26), SDNN 50ms and 50 ms, QTVI 0.5 and 0.5 (20), combination of presence of LP with EF 35%, combination of QTVI 0.5 and presence of LP. Statistical analysis was performed using Chisquare test for comparison of incidence of dichotomized values of noninvasive arrhythmia markers and unpaired students t test was applied for assessment of differences in quantitative variables (SPSS for Windows 10.0). To assess the value of combination of noninvasive arrhythmia markers in association with sustained ventricular arrhythmias, we used adjusted logistic stepwise regression analysis, where presence (encoded as 1) or absence (encoded as 0) of sustained VT was accepted as independent variable. While following parameters showing the statistically significant differences based on descriptive analysis as age and dichotomized noninvasive arrhythmia markers and their combinations were considered as dependent variables. Further forward stepwise regression analysis was attempted for selection of the best model, where variables with the significant P value were included into the model step-by-step until no more significant associates remain. Results As can be seen from Table 1 patients without VT/VF were older than those without arrhythmia (P.001); however, groups did not differ as regards
4 20 Journal of Electrocardiology Vol. 36 No. 1 January 2003 Table 2. Incidence of Positive and Negative Results of Noninvasive Arrhythmia Markers in Patients With and Without Sustained Ventricular Arrhythmias Parameters VT/VF Negative VT/VF Positive P LP ( ) (26), % 26.9 (7) 73.1 (19).001 LR 11.0, P.001 QTVI 0,5 (21), % 23.8 (5) 76.2 (16).002 LR 9.7, P.002 SDNN 50 ms (46) 47.8 (22) 52.2 (24) NS LR 0.54, NS EF 35%, (18) 22.2 (4) 77.8 (14).004 LR 8.6, P.003 EF 35% LP ( ) (10), % (10).0001 LR 16.1, P.0001 LP ( ) QTVI 0.5 (11), % (11).0001 LR 18.0, P.0001 EF, ejection fraction; LP, late potential; VT/VF, ventricular tachycardia/ventricular fibrillation; QTVI, QT variability index. to gender, risk factors of coronary artery disease and treatment, although class III antiarrhythmic agents were taken slightly more often by patients with VT/VF (P.05). Patients of group I had more often presented with syncope and palpitations on admission and 4 patients had history of aborted sudden death. Twenty patients of group I had monomorphic VT and 7 patients had polymorphic VT/VF during clinical observation and clinical VT/VF was induced during programmed ventricular stimulation in 19 of them. Patients did not differ as regards to mean number of stenosed vessels and incidence of IRA occlusion. Left ventricular ejection fraction was markedly lower (P.0001), SDNN was reduced (P.05), duration of fqrs and LAS40 were longer and QTVI was higher in patients with VT/VF (P.001, P.01 and P.001, respectively). There were no statistically significant differences in mean RR and QTc interval duration s between groups. Analysis of incidence of positive and negative results of noninvasive arrhythmia markers showed (Table 2) that LP were recorded in 26 patients and VT/VF were found in 73.1% of them (P.001). Increased QTVI ( 0.5) was found in 21 patients and VT/VF was documented in 76.2% of them (P.002). Reduced EF 35% was registered in 18 patients and 77.8% of them had sustained arrhythmia (P.001). Reduced SDNN was present in 46 patients and arrhythmia incidence was only 52.2% (P.05). Reduced LVEF and LP were found in 10 patients and all of them had sustained ventricular arrhythmia (P.0001). Eleven patients had both positive LP and increased QTVI and all of them had VT/VF (P.0001). Logistic regression analysis (Table 3) demonstrated that the highest odds ratio for having ventricular tachyarrhythmia had combination of LP and increased QTVI (15.4, P.0009), followed then by combination of LVEF and LP (12.2, P.0005), QTVI (P.0009), LVEF (P.001) alone, LP alone (P.002), and age (P.01). Forward stepwise regression analysis (Table 4) showed that the best model was those included combination of QTVI and LP (P.00001), age (P.005) and LVEF (P.01). Discussion Our study shows that patients presented with sustained VT/VF were older, the LVEF was lower and duration of filtered QRS and LAS40 were longer, while temporal liability of ventricular repolarization was significantly higher than in those without sustained arrhythmias. Analysis of the incidence of spontaneous sustained VT/VF according with the results of noninvasive risk stratification showed that when arrhythmia risk predictors were used alone the VT/VF incidence Table 3. Adjusted Logistic Regression Analysis Data and Odds Ratios of Noninvasive Arrhythmia Markers in Association With Ventricular Tachycardia/Ventricular Fibrillation Variable Odds Ratio P QTVI LP SDNN, ms 0.75 NS LVEF, % QTVI ( 0.5) LP ( ) EF ( 35%) LP ( ) Age, years LVEF, left ventricular ejection fraction; LP, late potential; QTVI, QT variability index; SDNN, standard deviation of normal to normal RR intervals.
5 QT Variability Data Potentials, Ventricular Tachycardia after MI Kudaiberdieva et al. 21 Table 4. Forward Stepwize Regression Analysis Data Variable 2 Log LR P QTVI ( 0.5) LP ( ) LVEF, % Age, years LVEF, left ventricular ejection fraction, LP, late potential; QTVI, QT variability index. ranged between 55.2% to 77.8% with the highest rate of serious arrhythmia in those with depressed LVEF. However, when the logistic stepwise regression analysis was used the odds ratio for association with ventricular tachycardia was the highest for combination of increased QT variability and late potentials, which appeared to be further strengthened when LVEF and age were added into the model. These mean that patients with late potentials, increased QT variability and LV dysfunction are at the highest risk for having ventricular tachycardia (Fig. 1). Late Potentials Our results on 73.1% incidence of LP in post-mi patients with sustained ventricular arrhythmias are close to the reported in previous studies, where LPs were detected in 73% to 100% of patients with sustained VT and only in 7% to 15% of those without (27). Zimmerman et al. (28) have also established that the predictors for LP in post-mi patients were LVEF 40% and occluded IRA. In their study the presence of ventricular LP, the total filtered QRS duration, the LAS-40 interval, older age and an occluded infarct-related artery were the only variables significantly associated with the occurrence of serious arrhythmic events during 70 months follow-up period (28). Recent studies on combination of LVEF 30% with LP showed that use of both markers could identify patients (of 260 patients - 36% had arrhythmic death and 44% cardiac death) at the risk for arrhythmic death during long-term follow-up period (11), being in accordance with our results showed the high pre- Fig. 1. Late potentials on the signal-averaged ECG (top left), reduced heart rate variability and increased QT variability tachograms (bottom left) in a patient with left ventricular dysfunction (EF 20%) postero-basal wall aneurysm, apical segments akinesia with thrombus (top right) and sustained ventricular tachycardia (bottom right).
6 22 Journal of Electrocardiology Vol. 36 No. 1 January 2003 dictive value of combination of LVEF and LP (P.0005). QT Interval Variability Index Our findings on increased QTVI in patients with sustained arrhythmias after MI are in agreement with the study of Atiga et al. (20) who have found that temporal lability of ventricular repolarization is increased in patients with sustained VT, most of them were with CAD, as compared with controls without arrhythmias and healthy subjects. Moreover, authors established that QTVI might work better than HRV and TWA in stratification for sudden death and was higher in those with VF. QTVI has been established to be enhanced in patients with ischemic and dilated cardiomyopathy, as well was found to correlate with other risk factors for sudden death in hypertrophic cardiomyopathy (18,19). Increased QTVI was found in 76.2% of patients with VT/VF in our study. Interestingly that combination of LP and QTVI was associated with much higher association with VT/VF (P.0002), than other risk stratifiers used alone or in combination. This association further has become stronger when accompanied by advanced age and lower left ventricular contractility. These findings on the combination of delayed conduction and repolarization alone better predict sustained VT/VF are in agreement with other study, that assessed predictive value of LP and other repolarization marker TWA in stratification of patients for arrhythmic events (13). Authors (13) have found that combination of LP and TWA had the highest predictive accuracy for arrhythmic events during 13 months of follow-up period 85%, independently of LVEF. It should be noted that assessment of repolarization abnormalities by TWA needs exercise testing or atrial pacing for abolishment of heart rate effects, while QTVI seems to be more easier to apply. Our findings support the opinion that combination of both depolarization and repolarization markers may increase susceptibility for VT/VF in post-mi patients (13). Our results may be explained by fact that MI leading to anatomical and electrical remodeling, namely LV dysfunction and inhomogenity of conduction between viable and non-viable tissues forms the substrate for arrhythmias and reentry (21,22). At the same time spatial and temporal heterogeneity of repolarization may predispose to arrhythmias (23,24). Experimental studies have documented that beta-to-beat variability of ventricular action potential duration was dependent on stochastic behavior of ionic channels and electrotonic interaction between cells (29). So, we could speculate that MI causing disruption of these electrotonic connections between cells as well ischemia leading to challenges in ionic gradients may lead to temporal dispersion of refractoriness and increase temporal lability of repolarization. Therefore, patients with MI and LV dysfunction, having both depolarization and repolarization abnormalities are prone to develop sustained ventricular arrhythmias. Our findings may assist in pre-selection of patients for risk stratification after MI (14) and could be applied as the first step strategy with bedside simple test with high-resolution ECG acquisition and assessment of LP and QTVI. Limitations of the study. The main limitations of the study are the small number of patients and slightly higher use of class III antiarrhythmic drugs in group of patients with ventricular tachycardia, however the QTc values did not differ between groups. Second, one could argue that control group also consists of patients with nonsustained VT that have also been shown to associate with the risk for sudden death. Although programmed ventricular stimulation failed to induce ventricular tachycardia in these patients, the value of QTVI in risk assessment in the latter category of patients needs further elucidation. It should also be emphasized that we did not include patients with bundle brunch block and atrial fibrillation, both of which have been associated with increased mortality in patients after myocardial infarction. In conclusion, patients with combination of positive LP or QTVI after MI have high likelihood for development of serious sustained arrhythmia. Simple bedside ECG recordings with further analysis of LP and QTVI may be applied as the first step strategy for identifying patients at risk for arrhythmia in patients after MI. References 1. Kleiger RE, Miller JP, Bigger JT, Moss AJ, and the Multicenter Post-Infarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 59:256, Farrell TG, Bashir Y, Cripps T, et al: Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardio-
7 QT Variability Data Potentials, Ventricular Tachycardia after MI Kudaiberdieva et al. 23 graphic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol. 18:687, Zuanetti G, Neilson JMM, Latini R, Santoro E, Maggioni AP, Ewing DJ, on Behalf of GISSI-2 Investigators. Prognostic Significance of Heart Rate Variability in Post-Myocardial Infarction Patients in the Fibrinolytic Era. The GISSI-2 Results. Circulation. 94:432, La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ, for the ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 478:351, El-Sherif N, Denes P, Katz R, et al: for the Cardiac Arrhythmia Suppression Trial/Signal-Averaged Electrocardiogram (CAST/SAECG) substudy investigators. Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arrhythmic events in the postinfarction period. J Am Coll Cardiol 25:908, Kuchar DL, Thorburn CW, Sammel NL: Prediction of serious arrhythmic events after myocardial infarction: signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography. J Am Coll Cardiol 9:531, Gomes JA, Winters SL, Stewart D, et al: A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: based on signal-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoring. J Am Coll Cardiol 10:349, Armoundas AA, Rosenbaum DS, Ruskin JN, et al: Prognostic significance of electrical alternans versus signal-averaged electrocardiography in predicting the outcome of electrophysiological testing and arrhythmia-free survival. Heart 80:251, Hohnloser SH, Klingenheben T, Li YG, et al: T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: Prospective comparison with conventional risk markers. J Cardiovasc Electrophysiol 9:1258, Lee KW, Okin PM, Kligfield P, et al: Precordial QT dispersion and inducible ventricular tachycardia. Am Heart J 134:1005, Gomes JA, Cain ME, Buxton AE, et al: Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation 104:436, Buxton AE, Hafley GE, Michael H. Lehmann ME, et al, for the Multicenter Unsustained Tachycardia Trial (MUSTT) Investigators. Prediction of sustained ventricular tachycardia inducible by programmed stimulation in patients with coronary artery disease. Utility of Clinical Variables. Circulation 99:1843, Ikeda T, Sakata T, Takami M, et al : Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study. J Am Coll Cardiol 35:722, Schmitt C, Barthel P, Ndrepepa C, et al: Value of programmed ventricular stimulation for prophylactic ınternal cardioverter defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers. J Am Coll Cardiol 37:1901, Moss AJ, Zareba W, Hall WJ, et al: The Multicenter Automatic Defibrillator Implantation Trial II Investigators Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877, Moss AJ, Hall WJ, Cannom DS, et al: For the MADIT trial investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933, Domanski MJ, Sakseena S, Epstein AE, for the AVID Investigators: Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. J Am Coll Cardiol 34:1090, Berger R, Kasper E, Baughman KL, Marban E, et al: Beat-to-beat QT interval variability. Novel evidence for repolarization lability in dilated cardiomyopathy. Circulation 96:1557, Atiga WL, Fananapazir L, McAreavey D, et al: Temporal repolarization lability in hypertrophic cardiomyopathy caused by b-myosin heavy-chain gene mutations. Circulation 101:1237, Atiga WL, Calkins H, Lawrence JH, et al: Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death. J Cardiovasc Electrophysiol 9:899, Gaudron P, Kugler I, Hu K, et al: Time course of cardiac structural, functional and electrical changes in asymptomatic patients after myocardial ınfarction: their ınter-relation and prognostic ımpact. J Am Coll Cardiol 38:33, Gardner PI, Ursell PC, Fenoglio JJ, Wit AL: Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts. Circulation 72:596, Adamson PB, Vanoli E: Early autonomic and repolarization abnormalities contribute to lethal arrhythmias in chronic ıschemic heart failure. characteristics of a novel heart failure model in dogs with postmyocardial ınfarction left ventricular dysfunction. J Am Coll Cardiol 37:1741, Viswanathan PC, Shaw RM, Rudy Y: Effects of Ikr and Iks heterogeneity on action potential duration and its rate dependence: a simulation study. Circulation 99:2466, Cheitlin MD, Alpert JS, Armstrong WF, et al: ACC/ AHA guidelines for the clinical application of echocardiography: a report of the American College of Cardiology/American Heart Association Task Force
8 24 Journal of Electrocardiology Vol. 36 No. 1 January 2003 on Practice Guidelines (Committee on Clinical Application of Echocardiography). Circulation 95:1686, Breithardt G, Cain ME, El-Sherif N, et al: Standards for analysis of ventricular late potentials using highresolution or signal-averaged electrocardiography: A statement by a task force committee of the European Society of Cardiology, the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 17:999, Borggrefe M, Fetsch T, Martinez-Rubio A, et al: Prediction of arrhythmia risk based on signal-averaged ECG in postinfarction patients. PACE 2566: 20 (Part II) :2566, Zimmermann A, Sentici A, Adamec R, et al: Longterm prognostic significance of ventricular late potentials after a first acute myocardial infarction. Am Heart J 134:1019, Zaniboni M, Pollard AE, Yang L, et al: Beat-to-beat repolarization variability in ventricular myocytes and its suppression by electrical coupling. Am J Physiol (Heart Circ Physiol) H677: 278:H677, 2000
20 ng/ml 200 ng/ml 1000 ng/ml chronic kidney disease CKD Brugada 5 Brugada Brugada 1
Symposium 39 45 1 1 2005 2008 108000 59000 55 1 3 0.045 1 1 90 95 5 10 60 30 Brugada 5 Brugada 80 15 Brugada 1 80 20 2 12 X 2 1 1 brain natriuretic peptide BNP 20 ng/ml 200 ng/ml 1000 ng/ml chronic kidney
More informationROLE OF THE SIGNAL ECG IN RISK STRATIFICATION OF SCD. An overview
ROLE OF THE SIGNAL ECG IN RISK STRATIFICATION OF SCD. An overview Nabil El-Sherif, MD SUNY - Downstate Medical Center & New York harbor VA Healthcare System Brooklyn, NY, USA Signal Averaged ECG: A Selective
More informationArrhythmias Focused Review. Who Needs An ICD?
Who Needs An ICD? Cesar Alberte, MD, Douglas P. Zipes, MD, Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN Sudden cardiac arrest is one of the most common causes
More informationPrediction of Life-Threatening Arrhythmia in Patients after Myocardial Infarction by Late Potentials, Ejection Fraction and Holter Monitoring
Prediction of Life-Threatening Arrhythmia in Patients after Myocardial Infarction by Late Potentials, Ejection Fraction and Holter Monitoring Yu-Zhen ZHANG, M.D.,* Shi-Wen WANG, M.D.,* Da-Yi Hu, M.D.,**
More informationImplantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure
Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure Wojciech Zareba Postinfarction patients with left ventricular dysfunction are at increased risk
More informationJournal of the American College of Cardiology Vol. 44, No. 7, by the American College of Cardiology Foundation ISSN /04/$30.
Journal of the American College of Cardiology Vol. 44, No. 7, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.06.063
More informationClinical and Electrocardiographic Characteristics of Patients with Brugada Syndrome: Report of Five Cases of Documented Ventricular Fibrillation
J Arrhythmia Vol 25 No 1 2009 Original Article Clinical and Electrocardiographic Characteristics of Patients with Brugada Syndrome: Report of Five Cases of Documented Ventricular Fibrillation Seiji Takashio
More informationSUDDEN CARDIAC DEATH(SCD): Definition
SUDDEN CARDIAC DEATH EPIDEMIOLOGY, PATHOPHYSIOLOGY, PREVENTION & THERAPY Hasan Garan, M.D. Columbia University Medical Center SUDDEN CARDIAC DEATH(SCD): Definition DEATH DUE TO A CARDIAC CAUSE IN A CLINICALLY
More informationSUDDEN CARDIAC DEATH(SCD): Definition
SUDDEN CARDIAC DEATH EPIDEMIOLOGY, PATHOPHYSIOLOGY, PREVENTION & THERAPY Hasan Garan, M.D. Columbia University Medical Center SUDDEN CARDIAC DEATH(SCD): Definition DEATH DUE TO A CARDIAC CAUSE IN A CLINICALLY
More informationPause-induced Ventricular Tachycardia: Clinical Characteristics
Pause-induced Ventricular Tachycardia: Clinical Characteristics Margaret Bond A. Study Purpose and Rationale Until three decades ago, ventricular arrhythmias were thought to be rare in occurrence and their
More informationThe Immediate Reproducibility of T Wave Alternans During Bicycle Exercise
Reprinted with permission from JOURNAL OF PACING AND CLINICAL ELECTROPHYSIOLOGY, Volume 25, No. 8, August 2002 Copyright 2002 by Futura Publishing Company, Inc., Armonk, NY 10504-0418. The Immediate Reproducibility
More informationICD in a young patient with syncope
ICD in a young patient with syncope Konstantinos P. Letsas, MD, FESC Second Department of Cardiology Evangelismos General Hospital of Athens Athens, Greece Case presentation A 17-year-old apparently healthy
More informationVentricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC
Ventricular Tachycardia Ablation Saverio Iacopino, MD, FACC, FESC ü Ventricular arrhythmias, both symptomatic and asymptomatic, are common, but syncope and SCD are infrequent initial manifestations of
More informationWhat Every Physician Should Know:
What Every Physician Should Know: The Canadian Heart Rhythm Society estimates that, in Canada, sudden cardiac death (SCD) is responsible for about 40,000 deaths annually; more than AIDS, breast cancer
More informationMEDICAL POLICY POLICY TITLE T-WAVE ALTERNANS TESTING POLICY NUMBER MP
Original Issue Date (Created): August 23, 2002 Most Recent Review Date (Revised): September 24, 2013 Effective Date: November 1, 2013 I. POLICY T-wave alternans is considered investigational as a technique
More informationNoninvasive Predictors of Sudden Cardiac Death
2011 년순환기관련학회춘계통합학술대회 Noninvasive Predictors of Sudden Cardiac Death 영남대학교의과대학순환기내과학교실신동구 Diseases associated with SCD Previous SCD event Prior episode of ventricular tachyarrhythmia Previous myocardial
More informationSignal-Averaged Electrocardiography (SAECG)
Medical Policy Manual Medicine, Policy No. 21 Signal-Averaged Electrocardiography (SAECG) Next Review: April 2018 Last Review: April 2017 Effective: May 1, 2017 IMPORTANT REMINDER Medical Policies are
More informationOriginal Article Fragmented QRS as a Predictor of Appropriate Implantable Cardioverter-defibrillator Therapy
4 Original Article Fragmented QRS as a Predictor of Appropriate Implantable Cardioverter-defibrillator Therapy Sirin Apiyasawat, Dujdao Sahasthas, Tachapong Ngarmukos, Pakorn Chandanamattha, Khanchit Likittanasombat
More informationQRS Duration Does Not Predict Occurrence of Ventricular Tachyarrhythmias in Patients With Implanted Cardioverter-Defibrillators
Journal of the American College of Cardiology Vol. 46, No. 2, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.03.060
More informationJournal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 37, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01133-5 Coronary
More informationEXPERT CONSENSUS DOCUMENT
EXPERT CONSENSUS DOCUMENT American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients
More informationICD. Guidelines and Critical Review of Trials. Win K. Shen, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Arizona Torino 2011
ICD Guidelines and Critical Review of Trials Win K. Shen, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Arizona Torino 2011 Disclosure Relevant Financial Relationship(s) None Off
More informationThe International Classification of Diseases, Tenth Revision,
AHA/ACCF/HRS Scientific Statement American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: signal_averaged_ecg 7/1992 10/2017 10/2018 10/2017 Description of Procedure or Service Signal-averaged electrocardiography
More informationIHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012
IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201203 JANUARY 24, 2012 The IHCP to reimburse implantable cardioverter defibrillators separately from outpatient implantation Effective March 1, 2012, the
More informationUse of Signal Averaged ECG and Spectral Analysis of Heart Rate Variability in Antiarrhythmic Therapy of Patients with Ventricular Tachycardia
October 1999 513 Use of Signal Averaged ECG and Spectral Analysis of Heart Rate Variability in Antiarrhythmic Therapy of Patients with Ventricular Tachycardia G.M. KAMALOV, A.S. GALYAVICH, N.R. KHASSANOV,
More information4/14/15. The Electrocardiogram. In jeopardy more than a century after its introduction by Willem Einthoven? Time for a revival. by Hein J.
The Electrocardiogram. In jeopardy more than a century after its introduction by Willem Einthoven? Time for a revival. by Hein J. Wellens MD 1 Einthoven, 1905 The ECG! Everywhere available! Easy and rapid
More informationThe Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia
The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia By Sandeep Joshi, MD and Jonathan S. Steinberg, MD Arrhythmia Service, Division of Cardiology
More informationSynopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist
Synopsis of Management on Ventricular arrhythmias M. Soni MD Interventional Cardiologist No financial disclosure Premature Ventricular Contraction (PVC) Ventricular Bigeminy Ventricular Trigeminy Multifocal
More informationJournal of the American College of Cardiology Vol. 41, No. 12, by the American College of Cardiology Foundation ISSN /03/$30.
Journal of the American College of Cardiology Vol. 41, No. 12, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00467-4
More informationAtrial fibrillation (AF) is a disorder seen
This Just In... An Update on Arrhythmia What do recent studies reveal about arrhythmia? In this article, the authors provide an update on atrial fibrillation and ventricular arrhythmia. Beth L. Abramson,
More informationClinical Policy: Holter Monitors Reference Number: CP.MP.113
Clinical Policy: Reference Number: CP.MP.113 Effective Date: 05/18 Last Review Date: 04/18 Coding Implications Revision Log Description Ambulatory electrocardiogram (ECG) monitoring provides a view of
More informationT-Wave Alternans. Policy # Original Effective Date: 06/05/2002 Current Effective Date: 09/17/2014
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationVentricular Arrhythmias in Acute MI Patients Undergoing Primary PCI
Ventricular Arrhythmias in Acute MI Patients Undergoing Primary PCI Bulent Gorenek MD FACC FESC Eskişehir Osmangazi University Cardiology Department Eskisehir-Turkey I do not have any potential conflict
More informationPreventing Sudden Death Current & Future Role of ICD Therapy
Preventing Sudden Death Current & Future Role of ICD Therapy Derek V Exner, MD, MPH, FRCPC, FACC, FAHA, FHRS Professor, Libin Cardiovascular Institute of Alberta Canada Research Chair, Cardiovascular Clinical
More informationEvaluation of Sum Absolute QRST Integral as a Clinical Marker for Ventricular Arrhythmias. Markus Kowalsky Group 11
Evaluation of Sum Absolute QRST Integral as a Clinical Marker for Ventricular Arrhythmias Markus Kowalsky Group 11 Selected Paper Ventricular arrhythmia is predicted by sum absolute QRST integral but not
More informationSluggish Upstroke of Signal-Averaged QRS Complex. An Arrhythmogenic Sign in Patients with Anteroseptal Myocardial Infarction
Original Article Sluggish Upstroke of Signal-Averaged QRS Complex. An Arrhythmogenic Sign in Patients with Anteroseptal Myocardial Infarction Masafumi Kanemura MD, Takao Katoh MD, Takashi Tanaka MD, Shin-ichiro
More informationMEDICAL POLICY SUBJECT: MICROVOLT T-WAVE ALTERNANS
MEDICAL POLICY PAGE: 1 OF: 6 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.
More informationSudden death as co-morbidity in patients following vascular intervention
Sudden death as co-morbidity in patients following vascular intervention Impact of ICD therapy Seah Nisam Director, Medical Science, Guidant Corporation Advanced Angioplasty Meeting (BCIS) London, 16 Jan,
More informationSummary, conclusions and future perspectives
Summary, conclusions and future perspectives Summary The general introduction (Chapter 1) of this thesis describes aspects of sudden cardiac death (SCD), ventricular arrhythmias, substrates for ventricular
More informationPrevention of Sudden Death in ARVC
ESC Munich, August 29, 2012 Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): Prevention of Sudden Death in ARVC Thomas Wichter, MD, FESC Professor of Medicine - Cardiology Marienhospital Osnabrück
More informationDo All Patients With An ICD Indication Need A BiV Pacing Device?
Do All Patients With An ICD Indication Need A BiV Pacing Device? Muhammad A. Hammouda, MD Electrophysiology Laboratory Department of Critical Care Medicine Cairo University Etiology and Pathophysiology
More informationLeft cardiac sympathectomy to manage beta-blocker resistant LQT patients
Left cardiac sympathectomy to manage beta-blocker resistant LQT patients Lexin Wang, M.D., Ph.D. Introduction Congenital long QT syndrome (LQTS) is a disorder of prolonged cardiac repolarization, manifested
More informationTachycardias II. Štěpán Havránek
Tachycardias II Štěpán Havránek Summary 1) Supraventricular (supraventricular rhythms) Atrial fibrillation and flutter Atrial ectopic tachycardia / extrabeats AV nodal reentrant a AV reentrant tachycardia
More informationPrevention of sudden cardiac death: With an emphasis on sudden cardiac death from ventricular arrhythmias
Prevention of sudden cardiac death: With an emphasis on sudden cardiac death from ventricular arrhythmias The Toronto ACS Summit Toronto, March 1, 2014 Andrew C.T. Ha, MD, MSc, FRCPC Cardiac Electrophysiology
More informationPOST-MYOCARDIAL INFARCTION ARRHYTHMIA RISK STRATIFICATION USING MICROVOLT T-WAVE ALTERNANS
CRAIOVA UNIVERSITY OF MEDICINE AND PHARMACY POST-MYOCARDIAL INFARCTION ARRHYTHMIA RISK STRATIFICATION USING MICROVOLT T-WAVE ALTERNANS PHD THESIS - ABSTRACT - PhD Supervisor: Prof. Dr. DOINA CÂRSTEA Candidate:
More informationSince their introduction in 1981, ventricular late potentials
Sudden Cardiac Death After Coronary Artery Bypass Grafting Is Not Predicted by Signal- Averaged ECG Christoph Scharf, MD, Hermann Redecker, MD, Firat Duru, MD, Reto Candinas, MD, Hans Peter Brunner-La
More informationSimulation of T-Wave Alternans and its Relation to the Duration of Ventricular Action Potentials Disturbance
The Open Pacing, Electrophysiology & Therapy Journal, 2010, 3, 21-27 21 Open Access Simulation of T-Wave Alternans and its Relation to the Duration of Ventricular Action Potentials Disturbance Dariusz
More informationThe patient with (without) an ICD and heart failure: Management of electrical storm
ISHNE Heart Failure Virtual Symposium April 2008 The patient with (without) an ICD and heart failure: Management of electrical storm Westfälische Wilhelms-Universität Münster Günter Breithardt, MD, FESC,
More informationΠρόληψη του ΑΚΘ σε ασθενείς με μη-ισχαιμική μυοκαρδιοπάθεια:
Πρόληψη του ΑΚΘ σε ασθενείς με μη-ισχαιμική μυοκαρδιοπάθεια: Νεώτερα δεδομένα στη διαστρωμάτωση κινδύνου Εμμ. Μ. Κανουπάκης MD, PhD, FESC Πανεπιστημιακό Νοσοκομείο Ηρακλείου NIDCM Presence of LV dilatation
More informationUse of Catheter Ablation in the Treatment of Ventricular Tachycardia Triggered by Premature Ventricular Contraction
J Arrhythmia Vol 22 No 3 2006 Case Report Use of Catheter Ablation in the Treatment of Ventricular Tachycardia Triggered by Premature Ventricular Contraction sao Kato MD, Toru wa MD, Yasushi Suzuki MD,
More informationSudden cardiac death: Primary and secondary prevention
Sudden cardiac death: Primary and secondary prevention By Kai Chi Chan Penultimate Year Medical Student St George s University of London at UNic Sheba Medical Centre Definition Sudden cardiac arrest (SCA)
More informationAnger-Induced T-Wave Alternans Predicts Future Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators
Journal of the American College of Cardiology Vol. 53, No. 9, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.10.053
More informationVentricular Arrhythmias
Presenting your most challenging cases Venice Arrhythmias Ventricular Arrhythmias Gioia Turitto, MD Presenter Disclosure Information A questionable indication for CRT-D in a patient with VT after successful
More informationRisk Stratification of Sudden Cardiac Death
Risk Stratification of Sudden Cardiac Death Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC USA Disclosures: None Sudden Cardiac Death A Major Public Health Problem > 1/2 of
More informationSudden Cardiac Death What an electrophysiologist thinks a cardiologist should know
Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know Steven J. Kalbfleisch, M.D. Medical Director Electrophysiology Laboratory Ross Heart Hospital Wexner Medical Center Sudden
More information03/17/16, 03/16/17, 03/15/18 CATEGORY: Technology Assessment. Proprietary Information of Excellus Health Plan, Inc.
MEDICAL POLICY SUBJECT: MICROVOLT T-WAVE ALTERNANS, PAGE: 1 OF: 6 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
More informationCME Article Brugada pattern masking anterior myocardial infarction
Electrocardiography Series Singapore Med J 2011; 52(9) : 647 CME Article Brugada pattern masking anterior myocardial infarction Seow S C, Omar A R, Hong E C T Cardiology Department, National University
More informationThe mortality of high-risk patients surviving myocardial
Arrhythmia/Electrophysiology Prevalent Low-Frequency Oscillation of Heart Rate Novel Predictor of Mortality After Myocardial Infarction Dan Wichterle, MD; Jan Simek, MD; Maria Teresa La Rovere, MD; Peter
More informationVentricular arrhythmias in acute coronary syndromes. Dimitrios Manolatos, MD, PhD, FESC Electrophysiology Lab Evaggelismos General Hospital
Ventricular arrhythmias in acute coronary syndromes Dimitrios Manolatos, MD, PhD, FESC Electrophysiology Lab Evaggelismos General Hospital introduction myocardial ischaemia and infarction leads to severe
More informationArrhythmias (II) Ventricular Arrhythmias. Disclosures
Arrhythmias (II) Ventricular Arrhythmias Amy Leigh Miller, MD, PhD Cardiovascular Electrophysiology, Brigham & Women s Hospital Disclosures None Rhythms and Mortality Implantable loop recorder post-mi
More information1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and
1 The clinical syndrome of heart failure in adults is commonly associated with the etiologies of ischemic and non-ischemic dilated cardiomyopathy, hypertrophic cardiomyopathy, hypertensive heart disease,
More informationESC Stockholm Arrhythmias & pacing
ESC Stockholm 2010 Take Home Messages for Practitioners Arrhythmias & pacing Prof. Panos E. Vardas Professor of Cardiology Heraklion University Hospital Crete, Greece Disclosures Small teaching fees from
More informationEHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs
EHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs Dear EHRA Member, Dear Colleague, As you know, the EHRA Accreditation Process is becoming increasingly recognised as an important step for
More informationVentricular tachycardia Ventricular fibrillation and ICD
EKG Conference Ventricular tachycardia Ventricular fibrillation and ICD Samsung Medical Center CCU D.I. Hur Ji Won 2006.05.20 Ventricular tachyarrhythmia ventricular tachycardia ventricular fibrillation
More informationClinical Policy: Microvolt T-Wave Alternans Testing Reference Number: CP.MP.212
Clinical Policy: Reference Number: CP.MP.212 Effective Date: 03/05 Last Review Date: 09/17 See Important Reminder at the end of this policy for important regulatory and legal information. Coding Implications
More informationJ Wave Syndromes. Osama Diab Lecturer of Cardiology Ain Shams University
J Wave Syndromes Osama Diab Lecturer of Cardiology Ain Shams University J Wave Syndromes Group of electric disorders characterized by > 1 mm elevation of the J point or prominent J wave with or without
More informationResponse of Right Ventricular Size to Treatment with Cardiac Resynchronization Therapy and the Risk of Ventricular Tachyarrhythmias in MADIT-CRT
Response of Right Ventricular Size to Treatment with Cardiac Resynchronization Therapy and the Risk of Ventricular Tachyarrhythmias in MADIT-CRT Heart Rhythm Society (May 11, 2012) Colin L. Doyle, BA,*
More informationAre there low risk patients in Brugada syndrome?
Are there low risk patients in Brugada syndrome? Pedro Brugada MD, PhD Andrea Sarkozy MD Risk stratification in Brugada syndrome In the last years risk stratification in Brugada syndrome has become the
More informationHeart Rhythm Disorders. How do you quantify risk?
Heart Rhythm Disorders How do you quantify risk? Heart Rhythm Disorders Scale of the Problem 1/2 population will have an episode of transient loss of consciousness (T-LOC) at some stage in their life.
More informationPrimary prevention ICD recipients: the need for defibrillator back-up after an event-free first battery service-life
Chapter 3 Primary prevention ICD recipients: the need for defibrillator back-up after an event-free first battery service-life Guido H. van Welsenes, MS, Johannes B. van Rees, MD, Joep Thijssen, MD, Serge
More informationUC San Diego UC San Diego Previously Published Works
UC San Diego UC San Diego Previously Published Works Title Abnormal heart rate turbulence predicts the initiation of ventricular arrhythmias Permalink https://escholarship.org/uc/item/4847v0bk Journal
More informationIndex. cardiacep.theclinics.com. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A AEDs. See Automated external defibrillators (AEDs) AF. See Atrial fibrillation (AF) Age as factor in SD in marathon runners, 45 Antiarrhythmic
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure (review
More informationShock Reduction Strategies Michael Geist E. Wolfson MC
Shock Reduction Strategies Michael Geist E. Wolfson MC Shock Therapy Thanks, I needed that! Why Do We Need To Reduce Shocks Long-term outcome after ICD and CRT implantation and influence of remote device
More informationAblative Therapy for Ventricular Tachycardia
Ablative Therapy for Ventricular Tachycardia Nitish Badhwar, MD, FACC, FHRS 2 nd Annual UC Davis Heart and Vascular Center Cardiovascular Nurse / Technologist Symposium May 5, 2012 Disclosures Research
More informationMethods. Washington, DC and Hines, Illinois
942 JACC Vol. 32, No. 4 Prevalence and Significance of Nonsustained Ventricular Tachycardia in Patients With Premature Ventricular Contractions and Heart Failure Treated With Vasodilator Therapy STEVEN
More informationMicrovolt T-Wave Alternans for Risk Stratification in Athletes with Ventricular Arrhythmias: Correlation with Programmed Ventricular Stimulation
Microvolt T-Wave Alternans for Risk Stratification in Athletes with Ventricular Arrhythmias: Correlation with Programmed Ventricular Stimulation Giuseppe Inama, M.D., Claudio Pedrinazzi, M.D., Ornella
More informationDifferences in the Slope of the QT-RR Relation Based on 24-Hour Holter ECG Recordings between Cardioembolic and Atherosclerotic Stroke
ORIGINAL ARTICLE Differences in the Slope of the QT-RR Relation Based on 24-Hour Holter ECG Recordings between Cardioembolic and Atherosclerotic Stroke Akira Fujiki 1 and Masao Sakabe 2 Abstract Objective
More informationTachycardia Devices Indications and Basic Trouble Shooting
Tachycardia Devices Indications and Basic Trouble Shooting Peter A. Brady, MD., FRCP Cardiology Review Course London, March 6 th, 2014 2011 MFMER 3134946-1 Tachycardia Devices ICD Indications Primary and
More informationMicrovolt T-Wave Alternans and the Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction
Journal of the American College of Cardiology Vol. 47, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.11.026
More informationELECTRO PHYSIOLOGIC STUDIES STEPHEN L. WINTERS, MD, FACC, DEBRA STEWART, RN, ADRIA TARGONSKI, MT, J. ANTHONY GOMES, MD, FACC
lacc Vol. 12, No.6 December 1988:1481-7 1481 ELECTRO PHYSOLOGC STUDES Role of Signal Averaging of the Surface QRS Complex in Selecting Patients With Nonsustained Ventricular Tachycardia and High Grade
More informationMichel Mirowski and colleagues ABSTRACT CARDIOLOGY. ICD Update: New Evidence and Emerging Clinical Roles in Primary Prevention of Sudden Cardiac Death
ICD Update: New Evidence and Emerging Clinical Roles in Primary Prevention of Sudden Cardiac Death Ronald D. Berger, MD, PhD, FACC ABSTRACT PURPOSE: To review recent major randomized trials of implantable
More informationKey words: acute myocardial infarction; external cardioversion; troponin T; ventricular arrhythmias
Cardiac Troponin T and Cardiac Enzymes After External Transthoracic Cardioversion of Ventricular Arrhythmias in Patients With Coronary Artery Disease* Omer Goktekin, MD; Mehmet Melek, MD; Bulent Gorenek,
More informationContinuing Cardiology Education
Continuing Cardiology Education REVIEW ARTICLE Risk stratification for the primary prevention of arrhythmic sudden cardiac death in post-infarction patients Part II: Cardiac magnetic resonance and electrophysiological
More informationAbbreviation List: 2017 by the American Heart Association, Inc. and the American College of Cardiology Foundation. 1
2017 AHA/ACC/HRS Systematic Review for the Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death Data Supplement Table of Contents Part 1. For Asymptomatic
More informationThe pill-in-the-pocket strategy for paroxysmal atrial fibrillation
The pill-in-the-pocket strategy for paroxysmal atrial fibrillation KONSTANTINOS P. LETSAS, MD, FEHRA LABORATORY OF CARDIAC ELECTROPHYSIOLOGY EVANGELISMOS GENERAL HOSPITAL OF ATHENS ARRHYTHMIAS UPDATE,
More informationNon-invasive sudden death risk stratification
Non-invasive sudden death risk stratification Roberto F.E. Pedretti, Simona Sarzi Braga Division of Cardiology, IRCCS S. Maugeri Foundation, Scientific Institute of Tradate, Tradate (VA), Italy Key words:
More informationElectrophysiologic investigation in Brugada syndrome
European Heart Journal (2002) 23, 1394 1401 doi:10.1053/euhj.2002.3256, available online at http://www.idealibrary.com on Electrophysiologic investigation in Brugada syndrome Yield of programmed ventricular
More informationManagement of Ventricular Arrhythmias A Trial-based Approach
Journal of the American College of Cardiology Vol. 34, No. 3, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00273-9 REVIEW
More informationA Study to Determine if T Wave Alternans is a Marker of Therapeutic Efficacy in the Long QT Syndrome
A Study to Determine if T Wave Alternans is a Marker of Therapeutic Efficacy in the Long QT Syndrome A. Tolat A. Statement of study rationale and purpose T wave alternans (TWA), an alteration of the amplitude
More informationBrugada syndrome is a cardiac disease caused by an
Efficacy of Quinidine in High-Risk Patients With Brugada Syndrome Bernard Belhassen, MD; Aharon Glick, MD; Sami Viskin, MD Background Automatic implantable cardioverter-defibrillator therapy is considered
More informationQT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy
European Heart Journal (1996) 17, 258-263 QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy L. Fei, J. H. Goldman,
More informationthat number is extremely high. It s 16 episodes, or in other words, it s 14, one-four, ICD shocks per patient per day.
Doctor Karlsner, Doctor Schumosky, ladies and gentlemen. It s my real pleasure to participate in this session on controversial issues in the management of ventricular tachycardia and I m sure that will
More informationThe Diagnosis of Cardiac Arrhythmias
2 The Diagnosis of Cardiac Arrhythmias Allison W. Richardson, MD, and Peter J. Zimetbaum, MD Contents Introduction The Initial Evaluation of the Patient With Palpitations or Syncope Diagnostic Testing
More informationElectrocardiographic Arrhythmia Risk Testing
Electrocardiographic Arrhythmia Risk Testing Gregory Engel, MD, James G. Beckerman, MD, Victor F. Froelicher, MD, Takuya Yamazaki, MD, Henry A. Chen, MD, Kelly Richardson, MD, Ryan J. McAuley, BS, Euan
More informationSecondary prevention of sudden cardiac death
Secondary prevention of sudden cardiac death Balbir Singh, MD, DM; Lakshmi N. Kottu, MBBS, Dip Card, PGPCard Department of Cardiology, Medanta Medcity Hospital, Gurgaon, India Abstract All randomised secondary
More informationPublic Statement: Medical Policy Statement:
Medical Policy Title: Cardioverter- ARBenefits Approval: 09/7/2011 Defibrillators Effective Date: 01/01/2012 Document: ARB0096 Revision Date: Code(s): C1721, C1722, C1777, C1882, C1895, C1896 and C1899
More informationNIH Public Access Author Manuscript Comput Cardiol (2010). Author manuscript; available in PMC 2011 July 11.
NIH Public Access Author Manuscript Published in final edited form as: Comput Cardiol (2010). 2010 September 26; 2010: 353 356. Torsadogenic Drug-induced Increased Short-term Variability of JT-area Xiao
More informationApical Hypertrophic Cardiomyopathy With Hemodynamically Unstable Ventricular Arrhythmia Atypical Presentation
Cronicon OPEN ACCESS Hemant Chaturvedi* Department of Cardiology, Non-Invasive Cardiology, Eternal Heart Care Center & research Institute, Rajasthan, India Received: September 15, 2015; Published: October
More information